120 related articles for article (PubMed ID: 16888619)
41. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
[No Abstract] [Full Text] [Related]
42. Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer.
Bochennek K; Allwinn R; Langer R; Becker M; Keppler OT; Klingebiel T; Lehrnbecher T
Vaccine; 2014 Jun; 32(27):3357-61. PubMed ID: 24793952
[TBL] [Abstract][Full Text] [Related]
43. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
[TBL] [Abstract][Full Text] [Related]
44. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA.
Groves FD; Gridley G; Wacholder S; Shu XO; Robison LL; Neglia JP; Linet MS
Br J Cancer; 1999 Sep; 81(1):175-8. PubMed ID: 10487630
[TBL] [Abstract][Full Text] [Related]
45. [Evolution of vaccine coverage from school year 2003-2004 to 2006-2007, for 5 to 6-year-old children in Geneva].
Jeannot E; Wyler Lazarevic CA; Duperrex O; Chastonay P
Med Mal Infect; 2010 Jan; 40(1):27-30. PubMed ID: 19615837
[TBL] [Abstract][Full Text] [Related]
46. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
[TBL] [Abstract][Full Text] [Related]
47. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.
van Tilburg CM; Bierings MB; Berbers GA; Wolfs TF; Pieters R; Bloem AC; Sanders EA
Pediatr Blood Cancer; 2012 May; 58(5):701-7. PubMed ID: 21793184
[TBL] [Abstract][Full Text] [Related]
48. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
[TBL] [Abstract][Full Text] [Related]
49. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
McCusker C; Somerville W; Grey V; Mazer B
Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
[TBL] [Abstract][Full Text] [Related]
50. Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia Growth and Development Study.
Hilgartner MW; Maeder MA; Mahoney EM; Donfield SM; Evatt BL; Hoots WK
Am J Hematol; 2001 Feb; 66(2):92-8. PubMed ID: 11421305
[TBL] [Abstract][Full Text] [Related]
51. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
52. Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination.
Fouda AE; Kandil SM; Boujettif F; Salama YS; Fayea NY
Hematology; 2018 Oct; 23(9):590-595. PubMed ID: 29614919
[TBL] [Abstract][Full Text] [Related]
53. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
[TBL] [Abstract][Full Text] [Related]
54. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
[TBL] [Abstract][Full Text] [Related]
55. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.
Fioredda F; Plebani A; Hanau G; Haupt R; Giacchino M; Barisone E; Balbo L; Castagnola E
Eur J Haematol; 2005 Jan; 74(1):20-3. PubMed ID: 15613102
[TBL] [Abstract][Full Text] [Related]
56. Childhood vaccinations and risk of acute lymphoblastic leukaemia in children.
Søegaard SH; Rostgaard K; Schmiegelow K; Kamper-Jørgensen M; Hargreave M; Hjalgrim H; Hviid A
Int J Epidemiol; 2017 Jun; 46(3):905-913. PubMed ID: 28431124
[TBL] [Abstract][Full Text] [Related]
57. SEROLOGICAL RESPONSE TO VACCINES IN CHILDREN WITH DIABETES.
Dashti AS; Alaei MR; Musavi Z; Faramarzi R; Mansouri F; Nasimfar A
Roum Arch Microbiol Immunol; 2015; 74(3-4):112-7. PubMed ID: 27328526
[TBL] [Abstract][Full Text] [Related]
58. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
Alfredsson R; Svensson E; Trollfors B; Borres MP
Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
[TBL] [Abstract][Full Text] [Related]
60. Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center.
Gouveia-Alves F; Gouveia R; Ginani VC; Seber A; Kuramoto DA; Murad GFA; Spina FG; Petrilli AS; Zecchin VG; Granato C; Carlesse F; de Moraes-Pinto MI
Transpl Infect Dis; 2018 Aug; 20(4):e12903. PubMed ID: 29668078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
